|
?:authorAffiliation
|
-
[\'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Global Health, Seattle, WA, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; Fred Hutchinson Cancer Research Center, Clinical Research Division, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Global Health, Seattle, WA, USA; Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Department of Pediatrics, University of Washington and Seattle Children\'s Research, Seattle, WA, USA.\', \'Department of Medicine, University of Washington, Seattle, WA, USA.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institute of Health, Bethesda, MD, USA. Electronic address: mpancera@fredhutch.org.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Global Health, Seattle, WA, USA. Electronic address: amcguire@fredhutch.org.\', \'Fred Hutchinson Cancer Research Center, Vaccines and Infectious Disease Division, Seattle, WA, USA; University of Washington, Department of Global Health, Seattle, WA, USA. Electronic address: lstamata@fredhutch.org.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}